Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEOGEN CORPNEOG · Entity 4338 | Vice President | October 26, 2023 | October 31, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEOGEN CORP
Report date October 26, 2023 · Filed October 31, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.48 · Expires 2030-10-26 | Direct | 225,196 |
Reported balance
After 2023-10-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-10-26 · Exercise / conversion · Acquired 25,004 · Balance 225,196 F1: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $15.48 · Expires 2026-10-26 | Direct | 34,038 |
Reported balance
After 2023-10-26 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-10-26 · Exercise / conversion · Acquired 14,574 · Balance 34,038 F1: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants |
Filing footnotes · ownership attribution and instrument terms
F1: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 06, 2020 Filed Feb 7, 2020 21:50 UTC | NEOGEN CORP NEOG · Entity 4338 | SaleCommon Stock | 1,472 | $70.01 | $103,054.72 |
DisclosureSEC source: 0000711377-20-000008 · primary_doc.xml · nonDerivative · entry 5 Lilly Jason Warren · CIK 0001790610 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,401 Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:50 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 1,199 | $40.46 | $48,514.54 |
DisclosureSEC source: 0000711377-20-000008 · primary_doc.xml · nonDerivative · entry 4 Lilly Jason Warren · CIK 0001790610 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:50 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 273 | $35.34 | $9,647.82 |
DisclosureSEC source: 0000711377-20-000008 · primary_doc.xml · nonDerivative · entry 3 Lilly Jason Warren · CIK 0001790610 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,674 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:50 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 3,892 | $0.00 Strike: $35.34 | $0.00 |
DisclosureSEC source: 0000711377-20-000008 · primary_doc.xml · derivative · entry 6 Lilly Jason Warren · CIK 0001790610 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,940 Underlying: Common Stock · 3,892 shares Expires 2020-11-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options were granted on 108/2015, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:50 UTC | NEOGEN CORP NEOG · Entity 4338 | SaleCommon Stock | 3,892 | $70.02 | $272,517.84 |
DisclosureSEC source: 0000711377-20-000008 · primary_doc.xml · nonDerivative · entry 2 Lilly Jason Warren · CIK 0001790610 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,401 Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:50 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 3,892 | $35.34 | $137,543.28 |
DisclosureSEC source: 0000711377-20-000008 · primary_doc.xml · nonDerivative · entry 1 Lilly Jason Warren · CIK 0001790610 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 13:57 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $35.34 | $0.00 |
DisclosureSEC source: 0000711377-19-000057 · primary_doc.xml · derivative · entry 3 Lilly Jason Warren · CIK 0001790610 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,832 Underlying: Common Stock · 2,500 shares Expires 2020-11-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options were granted 10/8/2015, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 13:57 UTC | NEOGEN CORP NEOG · Entity 4338 | SaleCommon Stock | 2,500 | $64.61 | $161,527.75 |
DisclosureSEC source: 0000711377-19-000057 · primary_doc.xml · nonDerivative · entry 2 Lilly Jason Warren · CIK 0001790610 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,401 Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 13:57 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 2,500 | $35.34 | $88,350.00 |
DisclosureSEC source: 0000711377-19-000057 · primary_doc.xml · nonDerivative · entry 1 Lilly Jason Warren · CIK 0001790610 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 16, 2019 Filed Oct 17, 2019 22:24 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $29.71 | $0.00 |
DisclosureSEC source: 0000711377-19-000050 · primary_doc.xml · derivative · entry 3 Lilly Jason Warren · CIK 0001790610 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,332 Underlying: Common Stock · 4,000 shares Expires 2019-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options were fully exercisable on 10/1/2019 Read SEC document |
| October 16, 2019 Filed Oct 17, 2019 22:24 UTC | NEOGEN CORP NEOG · Entity 4338 | SaleCommon Stock | 2,784 | $65.89 | $183,447.78 |
DisclosureSEC source: 0000711377-19-000050 · primary_doc.xml · nonDerivative · entry 2 Lilly Jason Warren · CIK 0001790610 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,401 Read SEC document |
| October 16, 2019 Filed Oct 17, 2019 22:24 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 4,000 | $29.71 | $118,830.00 |
DisclosureSEC source: 0000711377-19-000050 · primary_doc.xml · nonDerivative · entry 1 Lilly Jason Warren · CIK 0001790610 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 11, 2019 Filed Oct 15, 2019 21:57 UTC | NEOGEN CORP NEOG · Entity 4338 | GrantCommon Stock (Right to Buy) · Derivative | 33,000 | $0.00 Strike: $63.90 | $0.00 |
DisclosureSEC source: 0000711377-19-000047 · primary_doc.xml · derivative · entry 1 Lilly Jason Warren · CIK 0001790610 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,332 Underlying: Common Stock · 33,000 shares Expires 2024-11-11 F1 · derivative.exercise_date: Options were granted 10/11/2019, have five year lives, and vest in equal annual 20% installments on each of the first five anniversary dates of the grant Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.